BOSTON, MA—One-year outcomes from an early feasibility study (EFS) show durable improvements in symptoms and quality of life in symptomatic heart failure (HF) patients treated with a novel coronary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback